Hennion & Walsh Asset Management Inc. Has $1.56 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Hennion & Walsh Asset Management Inc. lessened its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 27.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 13,179 shares of the company's stock after selling 4,935 shares during the period. Hennion & Walsh Asset Management Inc.'s holdings in Cardinal Health were worth $1,559,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Carolina Wealth Advisors LLC boosted its holdings in shares of Cardinal Health by 346.9% in the fourth quarter. Carolina Wealth Advisors LLC now owns 1,917 shares of the company's stock valued at $227,000 after acquiring an additional 1,488 shares in the last quarter. Redhawk Wealth Advisors Inc. lifted its stake in Cardinal Health by 13.6% during the fourth quarter. Redhawk Wealth Advisors Inc. now owns 6,378 shares of the company's stock valued at $754,000 after purchasing an additional 764 shares during the last quarter. CHURCHILL MANAGEMENT Corp boosted its holdings in Cardinal Health by 1.5% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 240,422 shares of the company's stock worth $28,435,000 after buying an additional 3,576 shares in the last quarter. Burney Co. grew its position in Cardinal Health by 5.8% in the fourth quarter. Burney Co. now owns 38,577 shares of the company's stock worth $4,562,000 after buying an additional 2,116 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its holdings in shares of Cardinal Health by 21.6% in the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 821 shares of the company's stock valued at $97,000 after buying an additional 146 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Analysts Set New Price Targets

A number of research firms recently weighed in on CAH. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and increased their price target for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Barclays lifted their target price on shares of Cardinal Health from $117.00 to $133.00 and gave the stock an "overweight" rating in a research report on Monday, November 4th. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a report on Tuesday, January 7th. Morgan Stanley upped their price target on Cardinal Health from $127.00 to $136.00 and gave the company an "overweight" rating in a research report on Tuesday, December 17th. Finally, Wells Fargo & Company raised Cardinal Health from an "underweight" rating to an "equal weight" rating and lifted their target price for the company from $101.00 to $127.00 in a research note on Friday, December 13th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $133.29.

Cardinal Health Trading Down 0.6 %

Cardinal Health stock traded down $0.76 on Friday, reaching $126.27. 1,642,944 shares of the stock were exchanged, compared to its average volume of 1,877,583. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $127.27. The stock has a market cap of $30.56 billion, a PE ratio of 24.57, a PEG ratio of 1.48 and a beta of 0.63. The firm has a fifty day moving average price of $120.75 and a two-hundred day moving average price of $111.92.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The business had revenue of $52.28 billion for the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same period last year, the business earned $1.73 earnings per share. Equities analysts anticipate that Cardinal Health, Inc. will post 7.82 EPS for the current fiscal year.

Cardinal Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.60%. The ex-dividend date was Thursday, January 2nd. Cardinal Health's payout ratio is 39.30%.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.